🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To characterize the safety, tolerability, pharmacokinetics and immunogenici...
Status
Completed
Location
Multiple Locations
Start Date
2016-04-14
Trial ID
NCT02696642
Treatments Being Tested
The primary objectives of the Phase I study 15404 are to evaluate the safet...
Status
Completed
Location
National Cancer Center Hospital East
Start Date
2015-08-14
Trial ID
NCT02485119
Treatments Being Tested
The key purpose of the main part of the study is to assess efficacy and saf...
Status
Completed
Location
Mayo Clinic Hospital
Start Date
2017-05-26
Trial ID
NCT03102320
Treatments Being Tested
Characterize the safety, tolerability, ECG effects, pharmacokinetics and im...
Status
Completed
Location
UCLA-Santa Monica Medical Center
Start Date
2016-09-07
Trial ID
NCT02824042
Treatments Being Tested
The purpose of this study is to enable patients with solid tumors, who rece...
Status
Terminated
Location
University of Chicago
Start Date
2019-06-03
Trial ID
NCT03926143
Treatments Being Tested
Anetumab ravtansine is developed for the treatment of patients with recurre...
Status
Completed
Location
Rocky Mountain Cancer Centers
Start Date
2016-06-08
Trial ID
NCT02751918
Treatments Being Tested
The main purpose of the 15743 study is to assess efficacy and safety of ane...
Status
Completed
Location
Multiple Locations
Start Date
2015-12-03
Trial ID
NCT02610140
Treatments Being Tested